The Claim
In adults aged 65–85 undergoing a 13-week exercise program, once-weekly sirolimus 6 mg is associated with a higher total burden of adverse events compared to placebo, including a possibly drug-related serious infection (pneumonia), despite similar rates of any adverse event occurrence between groups.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Older adults taking a weekly 6 mg dose of sirolimus while exercising for 13 weeks may have more side effects overall than those taking a fake pill, including a serious lung infection like pneumonia, even though about the same number of people had side effects in both groups.
See the scientific wording
Once-weekly sirolimus 6 mg during a 13-week exercise program in adults aged 65–85 is associated with a higher total burden of adverse events compared to placebo, including a possibly drug-related serious infection (pneumonia), despite similar rates of any adverse event occurrence between groups.
What the research says
1 studyThe study found that older adults taking weekly sirolimus had more side effects overall than those on placebo, including a serious case of pneumonia, even though the same number of people in each group had at least one side effect.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.